José
Palacios Calvo
Profesor/a Titular Universidad
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublications in collaboration with researchers from Hospital Universitario Virgen del Rocío (82)
2023
-
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
International journal of molecular sciences, Vol. 24, Núm. 13
2022
-
The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors
American Journal of Surgical Pathology, Vol. 46, Núm. 11, pp. 1545-1553
2020
-
Low prevalence of HER2-positive breast carcinomas among screening detected breast cancers
Cancers, Vol. 12, Núm. 6, pp. 1-16
-
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)
American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161
2019
-
Clinical challenges and implications of intratumor heterogeneity
Revista Espanola de Patologia, Vol. 52, Núm. 4, pp. 234-241
-
Molecular basis of tumor heterogeneity in endometrial carcinosarcoma
Cancers, Vol. 11, Núm. 7
2018
-
Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2018), 20, 3, (274-285), 10.1007/s12094-017-1719-x)
Clinical and Translational Oncology
-
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447
-
Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia
-
Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 274-285
2017
-
Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH
Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691
2016
-
CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy
Histopathology, Vol. 69, Núm. 2, pp. 239-249
-
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
Oncotarget, Vol. 7, Núm. 35, pp. 56295-56308
-
Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors
Oncogene, Vol. 35, Núm. 21, pp. 2777-2788
2015
-
A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer
Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503
-
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
Endocrine-Related Cancer, Vol. 22, Núm. 3, pp. 443-454
2014
-
A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry
Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403
-
A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition
Journal of Pathology, Vol. 232, Núm. 3, pp. 319-329
-
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models
Journal of Pathology, Vol. 233, Núm. 2, pp. 124-137
-
Prognostic relevance of estrogen receptor-α Ser167 phosphorylation in stage II-III colon cancer patients
Human Pathology, Vol. 45, Núm. 12, pp. 2437-2446